💊
Rybelsus
semaglutide
Diabete mellito di tipo 2
✅ Autorizzato
✅
Nessun allarme attivo
Questo medicinale non presenta carenze in corso, lettere di sicurezza o richiami.
A cosa serve
Rybelsus is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise as monotherapy when metformin is considered inappropriate due to intolerance or contraindications in combination with other medicinal products for the treatment of diabetes. For study results with respect to combinations, effects on glycaemic control and cardiovascular events, and the populations studied, see sections 4.4, 4.5 and 5.1.
⚠️ Sicurezza del paziente
No
📚 Avvisi passati (2)
Pagina ufficiale EMA
https://www.ema.europa.eu/en/medicines/human/EPAR/rybelsus